Begoña Mellado

12PUBLICATIONS
81CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Neurology and neuromuscular diseasesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 28, 2026
Correction: Pérez et al. Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer. Biomedicines 2025, 13, 740.

|Jul 21, 2025
Safety and Efficacy of Tarlatamab in Patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study.

Rahul Aggarwal, Sylvie Rottey, Alice Bernard-Tessier

|Jul 12, 2025
Clinical and Transcriptomic Characterization of Metastatic Hormone-Sensitive Prostate Cancer Patients with Low PTEN Expression.

Marta Garcia de Herreros, Natalia Jiménez, Joan Padrosa

|Apr 17, 2025
Benefits of a mindfulness and compassion program for cancer patients: experience in a Spanish public hospital setting.

Marcial Arredondo, Ferran Mestanza, Ruth Carpio

|Mar 28, 2025
Biomarker-Based Nomogram to Predict Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer.

Meritxell Pérez, Juan José Lozano, Mercedes Ingelmo-Torres

|Feb 06, 2024
Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors.

Solange Peters, Eric Angevin, Teresa Alonso-Gordoa

Pageof 2

Frequent Collaborators

5 joint publications

Natalia Jiménez

3 joint publications

Laura Ferrer-Mileo

3 joint publications

Aleix Prat

2 joint publications

Vicenç Ruiz de Porras